News und Analysen
Swiss Life with continued growth and higher profit from operations in first half of 2025 – successful start to “Swiss Life 2027”
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Partners Group reports H1 results: management fees in line with AuM growth and increased performance fee guidance for full year
Partners Group appoints Tarak Mehta as Partner and Co-Head of Private Equity Goods & Products
Morgan Stanley Statement on Stress Capital Buffer
On August 29, 2025, the Board of Governors of the Federal Reserve System announced that it was continuing to review Morgan Stanley’s request for a downward adjustment to the Firm’s preliminary
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Walmart Leadership to Participate in Upcoming Investor Events
Walmart Inc. (NYSE: WMT) announced today that company leadership will participate in upcoming investor events. Links to those with live webcasts can be found on Walmart’s investor relations website
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application
Humana Announces New Agreements to Expand Specialized Care Programs for Patients Living with Musculoskeletal Conditions
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced new strategic, individual value-based care partnerships with Vori Health and HOPCo, in addition to the company’s
Chartis Names FICO an Enterprise Fraud Solutions Category Leader for Fifth Straight Report
Global analytics software leader FICO today announced that it has been named a category leader for enterprise fraud solutions for the fifth time in a row in Chartis’ Enterprise and Payment Fraud
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Gadoquatrane New Drug Application Accepted for Review by U.S. FDA
Bayer today announced that a New Drug Application (NDA) for its investigational contrast agent gadoquatrane has been accepted for review by the U.S. Food and Drug Administration (FDA). The NDA for
Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Dalata Hotel Group PLC: HOL-Holding(s) in Company*
Dexcom Announces Upcoming Conference Presentations
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the following upcoming investor conferences:
-
The 2025 Wells Fargo Healthcare Conference on
Partners Group's interim financial results as of 30 June 2025
Dalata Hotel Group PLC: HOL-Holding(s) in Company*